Overview

• Swiss pharmaceutical giant Roche will invest $50 billion in the U.S. over the next five years, focusing on research, development, and manufacturing expansion.
• The initiative will fund new and enhanced facilities across multiple states, supporting domestic production and supply chain resilience.
• Up to 12,000 jobs will be created, including 1,000 directly at Roche and 11,000 in roles supporting new production capacities.
• The investment seeks to reorient Roche's U.S. operations toward becoming a net exporter of medicines once new capacities are operational.
• The announcement follows recent tariff threats from President Trump and mirrors Novartis's $23 billion U.S. investment pledge earlier this month.